May 6 (Reuters) - Private biotech firm Partner Therapeutics said on Wednesday the U.S. Food and Drug Administration has granted a priority review voucher to its experimental bile ‌duct cancer drug as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results